Confidentiality, Privilege, and other Ethics Issues after the Merger: What to Do When You're in Post-Acquisition Dispute Litigation
20 March 2018
Mergers, acquisitions, and asset sales raise a number of ethical issues, including who controls the confidentiality and privilege after the deal closes. These questions become that much more important when the buyer and seller are embroiled in litigation after the deal, at which time shared confidentiality and privileges and use of such information as evidence can pose complicated and expensive challenges for all parties involved. On top of these considerations, lawyers must abide by additional rules concerning, for example, loyalty to clients.
Topics that Foley & Lardner attorneys Michael Thompson and Jasmine Coo will cover include:
- Legal and ethical authorities concerning attorneys’ confidentiality, privilege, and other ethical obligations, including ABA Model Rules 1.6 (Confidentiality of Information), 1.9 (Duties to Former Clients), 2.1 (Advisor), 3.7 (Lawyer as Witness), and ABA Informal Op. 857 (Attorney as Witness).
- Discussion of such issues as they arise in post-acquisition litigation and what you can do, both before the closing and after, to address them.
Related Insights
21 May 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)
We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.